Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
April 25 2024 - 6:00AM
Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology
company that uses proprietary gene editing technologies to develop
plant traits (or specific genetic characteristics) in seeds, today
announced that the company will report first quarter 2024 financial
results on Thursday, May 9, 2024. Cibus’ management team will host
a conference call and audio webcast at 4:30 p.m. ET on that day to
discuss the financial results and other company updates.
Title: Cibus, Inc. First Quarter 2024 Results
Conference Call Event Date: Thursday, May 9,
2024 Time: 4:30
p.m. ET Participant
Numbers: +1-877-704-4453 (U.S.), +1-201-389-0920
(International)
Event Link: https://investor.cibus.com/events
For interested individuals unable to join the
conference call, a dial-in replay of the call will be available
through Thursday, May 23, 2024 and can be accessed by dialing
+1-844-512-2921 (U.S.), +1-412-317-6671 (International) and
entering replay passcode: 13745788.
A live audio webcast of the call, along with
accompanying slides, will be available under "News & Events” in
the Investor section of the Company's website, investor.cibus.com.
An archived webcast will be available on the Company's website for
90 days after the event.
About Cibus Cibus is a leader in
gene edited productivity traits that address critical productivity
and sustainability challenges for farmers such as diseases and
pests which the United Nations estimates cost the global economy
approximately $300 billion annually. Cibus is not a seed company.
It is a technology company that uses gene editing to develop and
license traits to seed companies in exchange for royalties on seed
sales. Cibus' focus is productivity traits for the major global
crops such as canola, corn, rice, soybean, and wheat. Cibus is a
technology leader in high throughput gene editing technology that
enables Cibus to develop and commercialize plant traits at a
fraction of the time and cost of conventional breeding. Cibus has
developed a pipeline of five productivity traits including
important traits for Pod Shatter Reduction, Sclerotinia resistance,
and weed management. Its initial traits for Pod Shatter Reduction
and weed management are developed in collaborations with leading
seed companies. Its other pipeline traits including Sclerotinia
resistance are in advanced greenhouse and field trial stages.
Cibus Contacts: Investor
RelationsKaren Troeberktroeber@cibus.com 858-450-2636
Jeff Sonnek – ICRjeff.sonnek@icrinc.com
Media Relations
Colin Sanford colin@bioscribe.com 203-918-4347
Cibus (NASDAQ:CBUS)
Historical Stock Chart
From May 2024 to Jun 2024
Cibus (NASDAQ:CBUS)
Historical Stock Chart
From Jun 2023 to Jun 2024